Interestingly, we observed significant downregulation of IFN pathway genes in reactivated MG, a finding consistent with their known antiproliferative role in immune surveillance and tumor suppression (Durbin et al., 1996; Kaplan et al., 1998). The gene discussed is IFNA1; the disease is myasthenia gravis.